Does Renin ‐Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case–Control Study

ConclusionOur data do not support the hypothesis that ACE inhibitors/ARBs may be protective against atherosclerotic CVEs in LN patients.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Facr.22857

Source: Arthritis Care and Research - August 18, 2016 Category: Rheumatology Authors: Konstantinos Tselios, Dafna D. Gladman, Jiandong Su, Murray B. Urowitz Tags: Original Article Source Type: research

More News: Angioplasty | Arthritis | Cardiology | Cardiovascular | Congestive Heart Failure | Coronary Angioplasty | Coronary Artery Bypass Graft | Diabetes | Endocrinology | Heart | Heart Attack | Heart Failure | Ischemic Stroke | Lupus | Nephritis | Proteinuria | Rheumatology | Stroke | Study